The Securities and Exchange Commission has not necessarily reviewed the information in this filing and has not determined if it is accurate and complete. | |||||||||||||||||||||
|
UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 13FFORM 13F INFORMATION TABLE |
|
||||||||||||||||||||
| COLUMN 1 | COLUMN 2 | COLUMN 3 | COLUMN 4 | COLUMN 5 | COLUMN 6 | COLUMN 7 | COLUMN 8 | ||||
| VALUE | SHRS OR | SH/ | PUT/ | INVESTMENT | OTHER | VOTING AUTHORITY | |||||
| NAME OF ISSUER | TITLE OF CLASS | CUSIP | (x$1000) | PRN AMT | PRN | CALL | DISCRETION | MANAGER | SOLE | SHARED | NONE |
| POWERSHARES S&P 500 LOW VOLATILITY | COM | 46138E354 | 28,056,410 | 446,687 | SH | SOLE | 446,687 | 0 | 0 | ||
| ISHARES CORE S&P 500 INDEX ETF | COM | 464287200 | 268,081,194 | 601,470 | SH | SOLE | 601,470 | 0 | 0 | ||
| MIRUM PHARMACEUTICALS INC | COM | 604749101 | 308,862 | 11,939 | SH | SOLE | 11,939 | 0 | 0 | ||
| ARCELLX INC | COM | 03940C100 | 56,631 | 1,791 | SH | SOLE | 1,791 | 0 | 0 | ||